Annual report pursuant to Section 13 and 15(d)

Composition of Certain Financial Statement Items Equity Method and Non-marketable Equity Investments (Details)

v3.19.3
Composition of Certain Financial Statement Items Equity Method and Non-marketable Equity Investments (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 29, 2019
Sep. 30, 2018
Sep. 24, 2017
Equity Method and Non-marketable Equity Investments [Line Items]      
Equity method investments $ 343 $ 402  
Non-marketable equity investments 787 650  
Carrying value of equity method and non-marketable equity investments 1,130 1,052  
Accounts receivable from equity method investees 0 0  
Equity Method Investee [Member]      
Equity Method and Non-marketable Equity Investments [Line Items]      
Non-cash consideration received from equity method investee 98    
Other Restructuring [Member]      
Equity Method and Non-marketable Equity Investments [Line Items]      
Non-cash consideration received for divestiture 53    
Equity Method Investee [Member]      
Equity Method and Non-marketable Equity Investments [Line Items]      
Revenues from transactions with certain equity method investees $ 152 $ 100 $ 165